How much does a vial of Lapatinib cost approximately

Lapatinib(Lapatinib) is a small molecule tyrosine kinase inhibitor mainly used to treat patients with HER2-positive breast cancer. Its advantage is that it can inhibit both HER2 and EGFR (epidermal growth factor receptor) signaling pathways, thereby effectively blocking the proliferation and metastasis of tumor cells. It is a representative type of oral targeted drugs. Compared with traditional chemotherapy, lapatinib has the advantages of less toxic side effects, precise treatment, and convenient administration. It is especially suitable for patients who have previously received trastuzumab and other drugs but still have recurrence or metastasis. It can penetrate the blood-brain barrier and also shows certain efficacy in patients with brain metastasis breast cancer, which has unique clinical significance among similar drugs.

From a pharmacological mechanism, lapatinib inhibits the phosphorylation of HER2 and EGFR by reversibly competing with ATP binding sites, thereby blocking cell signaling and reducing cancer cell growth and division. Its multi-target characteristics allow it to form a synergistic effect with chemotherapy drugs, hormonal treatment drugs or other targeted drugs when used in combination to improve the overall therapeutic effect. With the deepening of research, multiple overseas studies have shown that lapatinib can not only be used for breast cancer, but may also show potential in HER2 overexpressing tumors such as gastric cancer and cholangiocarcinoma, showing its broad application prospects.

In terms of price, the original drug lapatinib was once produced by GlaxoSmithKline (GSK) and marketed in China. However, due to market factors and adjustments to medical insurance policies, it has been delisted in China. However, in overseas markets, original drugs are still on sale. Among them, the price of original drugs in Türkiye is relatively affordable, with a bottle size of 0.25g × 70 tablets costing about more than 2,000 yuan. In comparison, generic drugs in India and Bangladesh are more economical, with a price of about 600 yuan, and the drug ingredients, dosage and efficacy are basically the same as the original drugs.

Reference materials:https://medlineplus.gov/druginfo/meds/a607055.html